Status:
COMPLETED
Double Stimulation Followed by a Fresh Embryo Transfer
Lead Sponsor:
Fundación Santiago Dexeus Font
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Infertility
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
The major goal of controlled ovarian stimulation (COS) is to increase the number of oocytes harvested in order to result in the generation of a higher number of available embryos, extended embryo cult...
Detailed Description
In assisted reproductive technologies (ART), despite the progress of the last decades, the achievement of a live birth still remains a challenge, especially for some categories of patients such as the...
Eligibility Criteria
Inclusion
- Poor prognosis patients according to the POSEIDON group 3 \& 4 (based on AMH)
- AMH \<1.2
- age \<40 years old
- BMI \>18 and \<35 kg/m2
- Body weight \>50kg (in women \<36 years old body weight \>60kg)
Exclusion
- Maternal age \> 40 years
- History of untreated autoimmune, endocrine or metabolic disorders
- Previous ovarian cystectomy or oophorectomy
- Body weight \<50kg (and body weight \<60kg in women \<36 years old)
Key Trial Info
Start Date :
October 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04446845
Start Date
October 30 2020
End Date
May 2 2023
Last Update
May 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Quiron Dexeus
Barcelona, Spain, 08028